SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N 1994 The diagnosis of osteoporosis. J Bone Miner Res 9: 11371141.
  • 2
    Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S 1987 Genetic determinants of bone mass in adults: A twin study. J Clin Invest 80: 706710.
  • 3
    Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr 1991 Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 6: 561567.
  • 4
    Soroko SB, Barret-Connor E, Edelstein SL, Kritz-Silverstein D 1994 Family history of osteoporosis and bone mineral density at the axial skeleton: The Rancho Bernardo study. J Bone Miner Res 9: 761769.
  • 5
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles. Nature 367: 284287.
  • 6
    Tokita A, Matsumoto H, Morrison NA, Tawa T, Miura Y, Fukamauchi I, Mitsuhashi N, Irimoto M, Yamamori S, Miura M, Watanabe T, Kuwabara Y, Yabuta K, Eisman JA 1996 Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese wornen. J Bone Miner Res 11: 10031009.
  • 7
    Harris SS, Eccelesball TR, Gross C, Dawson-Hughes B, Feldman D 1997 The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 12: 10431048.
  • 8
    Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E 1997 A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12: 915921.
  • 9
    Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH 1996 Reduced bone density and osteoporosis associated with a polymorphic Spl binding site in the collagen type I-alfa1 gene. Nat Genet 14: 203205.
  • 10
    Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H 1996 Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11: 306311.
  • 11
    Masi L, Becherini L, Colli E, Gennari L, Mansani R, Falchetti A, Becorpi Am, Cepollaro C, Gonnelli S, Tanini A, and Brandi ML 1998 Polymorphism of the calcitonin receptor gene are associated with bone mineral density in postmenopausal italian women. Biochem Biophys Res Commun 248: 190195.
  • 12
    Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y 1997 Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12: 14381445.
  • 13
    Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts A. B., Sporn MB, Goeddel DV 1985 Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701705.
  • 14
    Randall LL, Hardy SJS 1989 Unity in function in the absence of consensus in sequence: Role of leader peptides in export. Science 243: 11561159.
  • 15
    Seyedin S M, Thompson AY, Bentz H, Rosen DM, McPherson M, Conti A, Siegel N R, Galluppi GR and Piez KA 1986 Cartilage-inducing factor-A. J Biol Chem 261: 56935695.
  • 16
    Bonewald LF and Mundy GR 1990 Role of transforming growth factor-beta in bone remodeling. Clin Orthop 250: 261276.
  • 17
    Mundy G RBonewald L F 1992 Transforming growth factor beta. In: GowenM (ed.) CytokinesBone Metabolism. CRC; Boca Raton, FL, U.S.A., pp. 93107.
  • 18
    Langdal BL, Knudsen JY, Jensen HK, Gregersen N, and Eriksen EF 1997 A sequence variation:713-8delC in transforming growth factor-beta1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic and normal women. Bone 20: 289294.
  • 19
    Derynck R, Rhee L, Chen EY, VAN-Tilburg A 1987 Intron-exon structure of the human transforming growth factor-beta precursor gene. Nucleic Acids Res 15: 31883189.
  • 20
    Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O 1996 Polymorphisms of the transforming growth factor-β l gene in relation to myocardial infarction and blood pressure. The etude Cas-temoin de l'infarctus du myocarde (ECTIM) study. Hypertension 28: 881887.
  • 21
    Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, and Ikeda K 1998 Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal women. J Bone Miner Res 13:10: 156976.
  • 22
    Cooper C, Melton LJ 1992 Vertebral fractures. Br Med J 304: 793794.
  • 23
    LoCascio V, Braga V, Bertoldo F, Bettica P, Fratta Pasini A, Stefani L, Moro L 1994 Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. Clin Endocrinol 41: 4751.
  • 24
    Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J 1994 Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J Clin Invest 94: 21302134.
  • 25
    Garnero P, Borel O, Sornay-Rendu E, Arlot ME, Delmas PD 1996 Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in post- menopausal women: The OFELY study. J Bone Miner Res 11: 827834.
  • 26
    Eisman JA 1995 Vitamin D receptor gene alleles and osteoporosis: An affirmative view. J Bone Miner Res 10: 12891293.
  • 27
    Peacock M 1995 Vitamin D receptor gene alleles and osteoporosis: A contrasting view. J Bone Miner Res 10: 12941297.
  • 28
    Hansen MA, Hassager C, Jensen SB, Christiansen C 1992 Is heritability a risk factor for postmenopausal osteoporosis? J Bone Miner Res 7: 10371043.
  • 29
    Seeman E, Hopper JL, Bach LA, Cooper ME, Parkinson E, McKay J, Jerumus G 1989 Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 320: 554558.
  • 30
    Eisman JA, Kelly P, Morrison NA, Sambrook PN 1992 Geneticenvironmental interaction on bone mass. In: CohnDV, GennariC, TashijanAH (eds.) Calcium Regulating Hormones. Elsevier Science Publisher B.V., Amsterdam, Netherls, pp. 376383.
  • 31
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density, from vitamin D receptor alleles. Nature 367: 284287.
  • 32
    Orwoll ES, Oviatt SK, Mann T 1990 The impact of osteophytics and vascular calcification on vertebral mineral density measurement in men. J Clin Endocrinol Metab 70: 12021207.
  • 33
    Oreffo ROC, Mundy GR, Seyedin SM, Bonewald LF 1989 Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem Biophys Res Commun 158: 817823.
  • 34
    Oursler MJ 1994 Osteoclast synthesis and secretion and activation of latent transforming growth factor-β. J Bone Miner Res 9: 443452.
  • 35
    Pacifici R 1996 Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11: 10431051.
  • 36
    Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsberg TC 1991 Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129: 33133320.
  • 37
    Mundy G R 1993 Local control of osteoclast function. Osteoporosis Int 3(Suppl 27): S126S127.
  • 38
    Johansen J, Riis BJ, Delmas PD, Christiansen C 1988 Plasma BGP: An indicator of spontaneous bone loss and effect of estrogen treatment in postmenopausal women. Eur J Clin Invest 18: 191195.
  • 39
    Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas DP 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72: 367373.